{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:24:48Z","timestamp":1790558688272,"version":"4.1.0"},"reference-count":56,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>GATA2 deficiency is an inherited or sporadic genetic disorder characterized by distinct cellular deficiency, bone marrow failure, various infections, lymphedema, pulmonary alveolar proteinosis, and predisposition to myeloid malignancies resulting from heterozygous loss-of-function mutations in the GATA2 gene. How heterozygous GATA2 mutations affect human hematopoietic development or cause characteristic cellular deficiency and eventual hypoplastic myelodysplastic syndrome or leukemia is not fully understood. We used induced pluripotent stem cells (iPSCs) to study hematopoietic development in the setting of GATA2 deficiency. We performed hematopoietic differentiation using iPSC derived from patients with GATA2 deficiency and examined their ability to commit to mesoderm, hemogenic endothelial precursors (HEPs), hematopoietic stem progenitor cells, and natural killer (NK) cells. Patient-derived iPSC, either derived from fibroblasts\/marrow stromal cells or peripheral blood mononuclear cells, did not show significant defects in committing to mesoderm, HEP, hematopoietic stem progenitor, or NK cells. However, HEP derived from GATA2-mutant iPSC showed impaired maturation toward hematopoietic lineages. Hematopoietic differentiation was nearly abolished from homozygous GATA2 knockout (KO) iPSC lines and markedly reduced in heterozygous KO lines compared with isogenic controls. On the other hand, correction of the mutated GATA2 allele in patient-specific iPSC did not alter hematopoietic development consistently in our model. GATA2 deficiency usually manifests within the first decade of life. Newborn and infant hematopoiesis appears to be grossly intact; therefore, our iPSC model indeed may resemble the disease phenotype, suggesting that other genetic, epigenetic, or environmental factors may contribute to bone marrow failure in these patients following birth. However, heterogeneity of PSC-based models and limitations of in vitro differentiation protocol may limit the possibility to detect subtle cellular phenotypes.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018017137","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T21:45:30Z","timestamp":1544564730000},"page":"3553-3565","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":37,"title":["GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1364-1814","authenticated-orcid":false,"given":"Moonjung","family":"Jung","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"},{"name":"Laboratory of Genome Maintenance, The Rockefeller University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Cordes","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhong","family":"Zou","sequence":"additional","affiliation":[{"name":"iPSC Core, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin J.","family":"Yu","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavi","family":"Guitart","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Gun","family":"Hong","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Dang","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Kang","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia S.","family":"Donaires","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Center for Molecular Modeling, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Albitar","sequence":"additional","affiliation":[{"name":"NeoGenomics Laboratories, Inc., Aliso Viejo, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6841-2122","authenticated-orcid":false,"given":"Amy P.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Holland","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Hickstein","sequence":"additional","affiliation":[{"name":"Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Townsley","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia E.","family":"Dunbar","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Winkler","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD;"},{"name":"Agios Pharmaceuticals, Inc., Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"issue":"8","key":"2021041619324720200_B1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2009-03-208629","article-title":"Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia","volume":"115","author":"Vinh","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2021041619324720200_B2","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2021041619324720200_B3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","article-title":"The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"208","author":"Bigley","year":"2011","journal-title":"J Exp Med"},{"issue":"10","key":"2021041619324720200_B4","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2021041619324720200_B5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2021041619324720200_B6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-07-517151","article-title":"The evolution of cellular deficiency in GATA2 mutation","volume":"123","author":"Dickinson","year":"2014","journal-title":"Blood"},{"issue":"10","key":"2021041619324720200_B7","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"2021041619324720200_B8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"2021041619324720200_B9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2021041619324720200_B10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2021041619324720200_B11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2015.137711","article-title":"Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome","volume":"101","author":"Nov\u00e1kov\u00e1","year":"2016","journal-title":"Haematologica"},{"issue":"10","key":"2021041619324720200_B12","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.3324\/haematol.2015.127092","article-title":"GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies","volume":"100","author":"Wang","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"2021041619324720200_B13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2 deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"issue":"2","key":"2021041619324720200_B14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.2013.090217","article-title":"Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation","volume":"99","author":"West","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"2021041619324720200_B15","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1128\/MCB.13.7.3999","article-title":"DNA-binding specificity of GATA family transcription factors","volume":"13","author":"Merika","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"21","key":"2021041619324720200_B16","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1242\/dev.080440","article-title":"Combinatorial regulation of tissue specification by GATA and FOG factors","volume":"139","author":"Chlon","year":"2012","journal-title":"Development"},{"issue":"2","key":"2021041619324720200_B17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cr.2015.6","article-title":"GATA family members as inducers for cellular reprogramming to pluripotency","volume":"25","author":"Shu","year":"2015","journal-title":"Cell Res"},{"issue":"13","key":"2021041619324720200_B18","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1093\/nar\/gks281","article-title":"Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies","volume":"40","author":"Bresnick","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"2021041619324720200_B19","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20130751","article-title":"Gata2 is required for HSC generation and survival","volume":"210","author":"de Pater","year":"2013","journal-title":"J Exp Med"},{"issue":"13","key":"2021041619324720200_B20","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1084\/jem.20130733","article-title":"Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo","volume":"210","author":"Gao","year":"2013","journal-title":"J Exp Med"},{"issue":"1","key":"2021041619324720200_B21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/leu.2017.196","article-title":"Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes","volume":"32","author":"Chong","year":"2018","journal-title":"Leukemia"},{"issue":"5","key":"2021041619324720200_B22","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.4049\/jimmunol.1401868","article-title":"GATA2 germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutation","volume":"194","author":"Cort\u00e9s-Lavaud","year":"2015","journal-title":"J Immunol"},{"issue":"19","key":"2021041619324720200_B23","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","article-title":"GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome","volume":"121","author":"Hsu","year":"2013","journal-title":"Blood"},{"issue":"6494","key":"2021041619324720200_B24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/371221a0","article-title":"An early haematopoietic defect in mice lacking the transcription factor GATA-2","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"issue":"7","key":"2021041619324720200_B25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.20031556","article-title":"GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells","volume":"200","author":"Ling","year":"2004","journal-title":"J Exp Med"},{"issue":"12","key":"2021041619324720200_B26","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/mt.2015.180","article-title":"Modeling human bone marrow failure syndromes using pluripotent stem cells and genome engineering","volume":"23","author":"Jung","year":"2015","journal-title":"Mol Ther"},{"issue":"3","key":"2021041619324720200_B27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.celrep.2012.08.002","article-title":"Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures","volume":"2","author":"Choi","year":"2012","journal-title":"Cell Reports"},{"key":"2021041619324720200_B28","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"2021041619324720200_B29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.stemcr.2015.12.009","article-title":"Genetic variability overrides the impact of parental cell type and determines iPSC differentiation potential","volume":"6","author":"Kytt\u00e4l\u00e4","year":"2016","journal-title":"Stem Cell Reports"},{"issue":"5","key":"2021041619324720200_B30","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.stem.2012.03.002","article-title":"Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells","volume":"10","author":"Young","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2021041619324720200_B31","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1182\/blood-2013-02-484444","article-title":"Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines","volume":"122","author":"Mills","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2021041619324720200_B32","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nbt.1667","article-title":"Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells","volume":"28","author":"Polo","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2021041619324720200_B33","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.stem.2012.02.013","article-title":"Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives","volume":"10","author":"Nazor","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2021041619324720200_B34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2011.06.007","article-title":"Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells","volume":"9","author":"Bar-Nur","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2021041619324720200_B35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"issue":"14","key":"2021041619324720200_B36","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood-2012-09-453969","article-title":"Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset","volume":"121","author":"Mace","year":"2013","journal-title":"Blood"},{"issue":"14","key":"2021041619324720200_B37","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood-2016-08-734236","article-title":"Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells","volume":"129","author":"Schlums","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2021041619324720200_B38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"issue":"1","key":"2021041619324720200_B39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B"},{"key":"2021041619324720200_B40","article-title":"TRANSFAC curated transcription factor targets","author":"Rouillard","year":"2016"},{"issue":"7390","key":"2021041619324720200_B41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature10807","article-title":"Control of ground-state pluripotency by allelic regulation of Nanog","volume":"483","author":"Miyanari","year":"2012","journal-title":"Nature"},{"issue":"4","key":"2021041619324720200_B42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.stem.2014.01.020","article-title":"Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cells","volume":"14","author":"Wu","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"14","key":"2021041619324720200_B43","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2016-08-734285","article-title":"Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs","volume":"129","author":"Corat","year":"2017","journal-title":"Blood"},{"issue":"17","key":"2021041619324720200_B44","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2014-10-570234","article-title":"De novo generation of HSCs from somatic and pluripotent stem cell sources","volume":"125","author":"Vo","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2021041619324720200_B45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.stem.2017.01.009","article-title":"Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia","volume":"20","author":"Kotini","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2021041619324720200_B46","first-page":"4","article-title":"GATA2(-\/-) human ESCs undergo attenuated endothelial to hematopoietic transition and thereafter granulocyte commitment","volume":"4","author":"Huang","year":"2015","journal-title":"Cell Regen (Lond)"},{"issue":"5","key":"2021041619324720200_B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.MCHD-0031-2016","article-title":"Myeloid cell origins, differentiation, and clinical implications","volume":"4","author":"Weiskopf","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"7139","key":"2021041619324720200_B48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature05725","article-title":"Cell tracing shows the contribution of the yolk sac to adult haematopoiesis","volume":"446","author":"Samokhvalov","year":"2007","journal-title":"Nature"},{"issue":"6","key":"2021041619324720200_B49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0092-8674(00)80165-8","article-title":"Definitive hematopoiesis is autonomously initiated by the AGM region","volume":"86","author":"Medvinsky","year":"1996","journal-title":"Cell"},{"issue":"2","key":"2021041619324720200_B50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ni1560","article-title":"Of lineage and legacy: the development of mammalian hematopoietic stem cells","volume":"9","author":"Dzierzak","year":"2008","journal-title":"Nat Immunol"},{"issue":"1","key":"2021041619324720200_B51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/MCB.13.1.473","article-title":"Hematopoietic commitment during embryonic stem cell differentiation in culture","volume":"13","author":"Keller","year":"1993","journal-title":"Mol Cell Biol"},{"issue":"6","key":"2021041619324720200_B52","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.celrep.2012.11.003","article-title":"T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures","volume":"2","author":"Kennedy","year":"2012","journal-title":"Cell Reports"},{"issue":"6","key":"2021041619324720200_B53","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nbt.2915","article-title":"Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells","volume":"32","author":"Sturgeon","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2021041619324720200_B54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3324\/haematol.2014.112144","article-title":"In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis","volume":"100","author":"Vanhee","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"2021041619324720200_B55","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.stemcr.2018.05.002","article-title":"GATA2 Is dispensable for specification of hemogenic endothelium but promotes endothelial-to-hematopoietic transition","volume":"11","author":"Kang","year":"2018","journal-title":"Stem Cell Reports"},{"issue":"7655","key":"2021041619324720200_B56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature22370","article-title":"Haematopoietic stem and progenitor cells from human pluripotent stem cells","volume":"545","author":"Sugimura","year":"2017","journal-title":"Nature"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/23\/3553\/1805625\/advances017137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/23\/3553\/1805625\/advances017137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T06:33:35Z","timestamp":1720852415000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/23\/3553\/16143\/GATA2-deficiency-and-human-hematopoietic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":56,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,12,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018017137","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]}}}